FUJIFILM Holdings

CSR activity report│Fighting Against COVID-19

Ultrasound Systems May Be Used to Rapidly Diagnose and Manage COVID-19 Complications

Able to contribute to the early response and assessment of the severity of the disease by diagnosis at various Point of Care locations

FFSS’s website provides a wealth of important information that can be used in the fight against COVID-19 (above)
FFSS employees shipping products in response to the rapid increase in global demand (below)

COVID-19 attacks the lungs, primarily in the initial stages of the disease, and often occurs quickly—within hours or minutes. Early detection and management of lung complications is therefore crucial.

Medical ultrasound may provide a minimally invasive examination that places less physical burden on the patient, and enables healthcare professionals to instantly observe images of the patient’s internal condition. This allows physicians to look for typical COVID-19 complications and assess the severity of the disease to determine the optimal disease management plan.

In particular, Point of Care Ultrasound (POCUS) may be carried directly to the patient’s location to enable rapid examination in the event of a sudden change in the patient’s physical condition.

FUJIFILM Sonosite, Inc. (FFSS) has received FDA 510(k) clearance for the company’s entire POCUS portfolio to support healthcare providers in performing accurate lung and cardiac imaging for COVID-19 patients. FFSS has published a COVID-19 Point-of-Care Ultrasound Guide, which explains to caregivers how ultrasound may be used to rapidly diagnose and manage COVID-19 complications. In addition, FFSS has provided additional educational materials, including a white paper and a variety of instructional videos to assist with the care of COVID-19 patients. These are posted in an online resource center, accessible through FFSS’s website.

FFSS ultrasound systems are known for durability, reliability, and ease-of-use, and are supported by the most in-depth educational resources available from any ultrasound manufacturer. FFSS systems are designed for portability and ease of disinfection. For these reasons FFSS ultrasound systems are highly valued by frontline healthcare workers around the world.

Time and time again Point-of-Care ultrasound has been a key component in managing COVID-19 patients. As COVID-19 continues to spread across the globe. FFSS will work with healthcare providers to support their efforts to save lives from the ravages of this terrible pandemic.

  • * This page contains some excerpts from the Sustainability Report.